- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Swedish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
3
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BIOT New | SEK 120.30 | -11.9% | -28.8% | SEK 9.6b | SEK 155.00 | PE33.9x | E20.4% | 1.4% | ||
ALIF B | SEK 166.40 | -5.0% | 64.1% | SEK 20.3b | SEK 184.00 | PE80.5x | E30.2% | 0.5% | ||
BONEX | SEK 339.80 | 3.1% | 75.6% | SEK 22.4b | SEK 422.33 | PE246.9x | E73.1% | n/a |
Page 1 of 1